Literature DB >> 15937360

A gel-based dual antibody capture and detection method for assaying of extracellular cytokine secretion: EliCell.

Lisa A Spencer1, Rossana C N Melo, Sandra A C Perez, Peter F Weller.   

Abstract

A distinguishing feature of eosinophils is their ability to rapidly release preformed cytokines from intracellular pools. Cytokines are delivered to the cell surface from granule stores by transport vesicles and are released in small packets at discrete locations along the cell surface through a process termed "piecemeal" degranulation. The study of this process has been hindered by lack of an assay sensitive enough to register minute protein concentrations and the inability to visualize morphology of cytokine secreting cells. These hindrances have necessitated our development of the EliCell assay, an agarose-based dual cytokine capture and detection system through which cytokine secretion and cellular morphology may be analyzed in concert. Cells are embedded within capture antibody-containing agarose and stimulated under conditions of interest. Extracellularly released cytokine is captured within the matrix at the point of release from the cell and can be labeled with a fluorochrome-conjugated antibody. Cytokine release and cellular morphology are visualized in parallel by phase contrast and fluorescence microscopy, respectively.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15937360      PMCID: PMC2716390          DOI: 10.1385/1-59259-903-6:297

Source DB:  PubMed          Journal:  Methods Mol Biol        ISSN: 1064-3745


  19 in total

1.  Cutting edge: eotaxin elicits rapid vesicular transport-mediated release of preformed IL-4 from human eosinophils.

Authors:  C Bandeira-Melo; K Sugiyama; L J Woods; P F Weller
Journal:  J Immunol       Date:  2001-04-15       Impact factor: 5.422

2.  EliCell assay for the detection of released cytokines from eosinophils.

Authors:  Christianne Bandeira-Melo; Sandra A C Perez; Rossana C N Melo; Ionita Ghiran; Peter F Weller
Journal:  J Immunol Methods       Date:  2003-05-01       Impact factor: 2.303

3.  Cell-adhesive properties of streptavidin are mediated by the exposure of an RGD-like RYD site.

Authors:  R Alon; E A Bayer; M Wilchek
Journal:  Eur J Cell Biol       Date:  1992-08       Impact factor: 4.492

4.  Streptavidin blocks immune reactions mediated by fibronectin-VLA-5 recognition through an Arg-Gly-Asp mimicking site.

Authors:  R Alon; R Hershkoviz; E A Bayer; M Wilchek; O Lider
Journal:  Eur J Immunol       Date:  1993-04       Impact factor: 5.532

5.  Cell adhesion to streptavidin via RGD-dependent integrins.

Authors:  R Alon; E A Bayer; M Wilchek
Journal:  Eur J Cell Biol       Date:  1993-02       Impact factor: 4.492

6.  Eosinophils express functional IL-13 in eosinophilic inflammatory diseases.

Authors:  Peter Schmid-Grendelmeier; Frank Altznauer; Barbra Fischer; Christian Bizer; Alex Straumann; Günter Menz; Kurt Blaser; Brunello Wüthrich; Hans-Uwe Simon
Journal:  J Immunol       Date:  2002-07-15       Impact factor: 5.422

Review 7.  The biology of the eosinophilic leukocyte.

Authors:  G J Gleich; C R Adolphson; K M Leiferman
Journal:  Annu Rev Med       Date:  1993       Impact factor: 13.739

Review 8.  Eokines: synthesis, storage and release from human eosinophils.

Authors:  P Lacy; R Moqbel
Journal:  Mem Inst Oswaldo Cruz       Date:  1997       Impact factor: 2.743

9.  Two integrin-binding peptides abrogate T cell-mediated immune responses in vivo.

Authors:  T A Ferguson; H Mizutani; T S Kupper
Journal:  Proc Natl Acad Sci U S A       Date:  1991-09-15       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.